![](/img/cover-not-exists.png)
The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer
David Knight, Amy C. Peterson, Brian I. Rini, Helena Harlin, Thomas F. Gajewski, Walter M. StadlerVolume:
69
Year:
2009
Language:
english
Pages:
7
DOI:
10.1002/pros.20864
File:
PDF, 114 KB
english, 2009